(2,3,4,5,6-Pentafluorophenyl) 2,4,4-trimethylpentanoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 英文名称: (2,3,4,5,6-Pentafluorophenyl) 2,4,4-trimethylpentanoate
• 英文别名: (2,3,4,5,6-pentafluorophenyl) 2,4,4-trimethylpentanoate
• 化学式: C₁₄H₁₅F₅O₂
• 分子量: 310.26
• InChiKey: MCCBBFMZZQANKR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• SURFACE TREATMENT LIQUID AND SURFACE TREATMENT METHOD
  申请人：Tokyo Ohka Kogyo Co., Ltd.

  公开号：EP3604467A1

  公开（公告）日：2020-02-05

  The purpose of the present invention is to provide: a surface treatment liquid that is capable of favorably hydrophilizing or hydrophobing surfaces of an object to be treated without having to include a film forming resin; and a surface treatment method using the surface treatment liquid. The present invention provides a surface treatment liquid which comprises (A) a resin and (C) a solvent, wherein as (A) the resin, a resin is used which has a weight average molecular weight of 100000 or more and contains a functional group I which comprises one group or more selected from the group consisting of a hydroxyl group, a cyano group, and a carboxyl group, and a functional group II which is a hydrophilic group or a hydrophobic group other than the functional group I.

  本发明的目的是提供：一种表面处理液，它能够使待处理物体的表面亲水或吸水，而不必包括成膜树脂；以及一种使用该表面处理液的表面处理方法。本发明提供了一种表面处理液，它由(A)树脂和(C)溶剂组成，其中作为(A)树脂，所使用的树脂的重量平均分子量为 100000 或更大，并含有一个官能团 I，该官能团 I 包括一个或多个从羟基、氰基和羧基组成的组中选出的基团，以及一个官能团 II，该官能团 II 是官能团 I 以外的亲水基团或疏水基团。
• POLYMERIC NANOPARTICLES FOR DRUG DELIVERY
  申请人：Borros Gomez Salvador

  公开号：US20140213641A1

  公开（公告）日：2014-07-31

  Disclosed are nanoparticles comprising a block copolymer and optionally one or more active agent(s), compositions comprising said nanoparticles and methods of preparing said nanoparticles. The block copolymer comprises blocks (i) a first polymer that is a polyester or polyamide and (ii) a second polymer comprising a hydrocarbon chain containing ester or ether bonds with hydroxyl number ≧10. The active agent(s) may be present within the nanoparticles or on the surfaces of the nanoparticles. The nanoparticles may optionally be associated with a surface-modifying moiety such that they are useful as drug delivery and molecular imaging devices. The surface-modifying moiety may target the nanoparticles to a desired target, cell, tissue or biomarker.